IP-owned developed of new innovative and tested delivery systems.
• Two products ready to market: • Sublingual Soluble tablet: replacement of smoking, pain treatment. more than 10 million potential patients in the approved MMJ states. • Topical crème: Treatment for different skin diseases starting with tested psoriasis. ~8 Million Psoriasis patients US & Canada (2.5% of population), 3 years potential is 2-4 millions monthly income (following current market prices)